Oncology

Therapeutics, diagnostics and evidence shaping cancer care.

Breast Cancer Endocrine Therapy Adherence Falters Over Menopause Care Gap

Breast cancer survivors often stop endocrine therapy because menopausal symptoms are unmanaged, exposing a gap in survivorship care and adherence.

By Dr. Revathy Mohan V.R., MBBS · Nov 5, 2026 · 5 min read

Oncology·Br J Cancer

Prostate cancer radiotherapy fatigue can persist for five years, REQUITE finds

In REQUITE, fatigue persisted in a substantial minority of men after prostate radiotherapy, with baseline fatigue and diabetes…

Nov 5, 2026

Oncology·Nat Rev Onc

Surgical Consolidation in Oligometastatic Gastro-Oesophageal Cancer Falls Short in RENAISSANCE

RENAISSANCE found no overall survival benefit for surgery after induction FLOT in limited-metastatic gastro-oesophageal adenocarcinoma, with notable postoperative…

Nov 5, 2026

Oncology·PLOS ONE

PLOS One flags figure concerns in breast cancer lectin study

PLOS One issued an editorial note on a breast cancer lectin paper after concerns were raised about results…

Nov 5, 2026

Oncology·PLOS ONE

Sex differences shape ICI survival benefit in advanced NSCLC meta-analysis

A meta-analysis of 42 trials found immune checkpoint inhibitors improved survival in both sexes, but benefits were larger…

Nov 5, 2026

Oncology·ClinicalTrials

KAN-001 Phase 1 Trial Tests Microbiome Therapy in Lung Cancer

Phase 1 study will test KAN-001 with pembrolizumab, with or without chemotherapy, in PD-L1-positive metastatic or inoperable NSCLC.

Nov 5, 2026

Oncology·ClinicalTrials

Mesothelin CAR-Mix cell trial targets advanced solid tumors with peritoneal spread

Zhejiang University is launching a phase 1 intraperitoneal SY001 study in mesothelin-positive advanced solid tumors with peritoneal metastasis.

Nov 5, 2026

Oncology·ClinicalTrials

Psilocybin Trial Targets Fear of Cancer Recurrence in Breast Cancer

NYU Langone will test psilocybin-assisted psychotherapy for fear of cancer recurrence, anxiety, depression and quality of life in…

Nov 5, 2026

Oncology·Med News Today

Oxaloacetate may ease brain fog and fatigue after breast cancer treatment

A small phase 2 study found oxaloacetate improved cognitive symptoms, fatigue and insomnia after breast cancer treatment, with…

Nov 4, 2026

Oncology·Med News Today

ctDNA blood test may detect lung cancer recurrence before scans

A liquid biopsy for ctDNA detected lung cancer recurrence months before scans in a small study, raising hopes…

Nov 4, 2026

Oncology

Therapeutics, diagnostics and evidence shaping cancer care.

In Brief The 5-minute rounds

New hypertension guideline lowers the treatment threshold to 130/80 mm Hg.
Phase 3 GLP-1 trial reports a 20% cut in major adverse cardiac events.
FDA clears a next-generation CAR-T therapy for relapsed lymphoma.
Meta-analysis links early mobilisation to shorter ICU length of stay.
Rapid guidance broadens empiric antibiotics for suspected sepsis.